SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-047110
Filing Date
2024-02-27
Accepted
2024-02-27 08:04:42
Documents
16
Period of Report
2024-02-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d795805d8k.htm   iXBRL 8-K 24792
2 EX-99.1 d795805dex991.htm EX-99.1 14335
6 GRAPHIC g795805g0226191619449.jpg GRAPHIC 2934
  Complete submission text file 0001193125-24-047110.txt   167381

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nerv-20240226.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20240226_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20240226_pre.xml EX-101.PRE 10838
18 EXTRACTED XBRL INSTANCE DOCUMENT d795805d8k_htm.xml XML 3545
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 24682055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)